Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A prospective, double blind, randomized, placebo controlled, outpatient, parallel group
comparison trial to assess the safety and efficacy of HO/03/03 10µg versus Placebo, applied
topically once daily for up to 14 weeks in at least 196 subjects diagnosed with Diabetes
Mellitus and having a single target non-healing Plantar Neuropathic Diabetic Foot Ulcer.